Infinitus Meets 520 Social Responsibility Day Goal for 5 Years, Promoting Healthy Living
GUANGZHOU, China, May 24, 2023 /PRNewswire/ -- On May 20, Infinitus hosted the 520 Infinitus Social Responsibility Day for the 5th consecutive year at Infinitus Plaza in Guangzhou, centered around this year's theme, "You and I Together for a Healthy Lifestyle". The event, broadcasted live online, aimed to inspire everyone to positively embrace a healthy lifestyle. ...
EirGenix Showcases Dual-Track Biosimilars and CDMO Strategy in U.S. Market Push at BIO 2026
SAN DIEGO, June 30, 2026 /PRNewswire/ -- At BIO 2026, EirGenix presented its comprehensive HER2-positive breast cancer biosimilar portfolio and highlighted its integrated one-stop contract development and manufacturing organization (CDMO) service platform. The company actively pursued U.S. market opportunities through business matchmaking and global partnership discussions. While antibody-drug conjugates, other oncology and immunology biologics, and biosimilars continue to...
Everest Medicines to Announce Full-Year 2021 Financial Results on March 29, 2022
SHANGHAI, March 15, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets, today announced that it will report financial results for the full year ended December 31, 2021 and provide a business update on March 29, 2022....
GlobalHealth Asia-Pacific recognises Amaris B. Clinic as the Gynecomastia Clinic of the Year in Asia Pacific 2022
The award is a recognition of excellence among medical providers in the Asia Pacific region, as acknowledged by leading professionals in healthcare providers and organisations in the sector. SINGAPORE, Sept. 13, 2022 /PRNewswire/ -- Amaris B. Clinic, led by Dr Ivan Puah, MOH accredited liposuction doctor and Chairman of Lipo Peer Review Committee in Singapore, was awarded "Gynecomastia...
ERT and Bioclinica become Clario, The Leading Technology Solutions Company for Clinical Trial Innovation and Evidence
PHILADELPHIA, Nov. 3, 2021 /PRNewswire/ -- ERT, the global clinical endpoint technology leader, today announced that following its early Q2 merger with Bioclinica, a technological and scientific leader in medical imaging, the combined company is renamed Clario. Clario is a technology company that generates the richest clinical evidence by fusing scientific expertise and...
DISCOVERY LIFE SCIENCES INSTALLS WORLD’S LARGEST COMMERCIAL FLEET OF NOVASEQ X PLUS SYSTEMS TO ACCELERATE GENOMIC RESEARCH WITH UNPRECEDENTED SPEED AND COST EFFICIENCY
HUNTSVILLE, Ala., March 30, 2023 /PRNewswire/ -- Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has announced that Discovery Genomics is the first commercial service laboratory in the world to receive two of the new NovaSeq™ X Plus Sequencing Systems from Illumina, Inc. Discovery Genomics will expand its platform to five systems by...
Lunit to Advance Singapore’s Healthcare System with AI-powered Solution for Medical Imaging
Lunit INSIGHT CXR is piloted at Singapore General Hospital and Changi General Hospital through AimSG, a national medical imaging AI platform for Singapore's Public Healthcare SEOUL, South Korea, Nov. 30, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, partners with NTT DATA...
Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States
TAMPA, Fla., Jan. 17, 2025 /PRNewswire/ -- Concept Medical Inc., a global pioneer in innovative drug delivery technology, is proud to announce the successful enrolment of the first patient in the "MAGICAL BTK" (Randomized Controlled Trial of MagicTouch PTA – Sirolimus Coated Balloon Versus Standard Balloon Angioplasty in the Treatment of Below The...
Wyeth Becomes the First Multinational Company to Launch an HMO Growing-Up Infant Formula in China
SUZHOU, China, Nov. 14, 2023 /PRNewswire/ -- On November 13th, 2023, Wyeth Nutrition announced the launch of its first illuma HMO Growing-up infant formula added with two human milk oligosaccharides (HMOs) in China. Designed for babies above 3 years old, this product is manufactured at the company's GMP-level factory in Suzhou. Illuma is now the first international company to introduce...
Zeus Names New Chief Executive Officer
Zeus, a leading supplier of custom polymer components to the world's most innovative medical device and industrial companies, names Padraic "Paddy" O'Brien as new CEO O'Brien joins Zeus at a pivotal moment as the company enters a new chapter of growth under EQT ownership O'Brien currently serves as Worldwide President of...
